These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 36303552)
1. Pathogenic variants of ornithine transcarbamylase deficiency: Nation-wide study in Japan and literature review. Kido J; Sugawara K; Sawada T; Matsumoto S; Nakamura K Front Genet; 2022; 13():952467. PubMed ID: 36303552 [TBL] [Abstract][Full Text] [Related]
2. Variant analysis and PGT-M of OTC gene in a Chinese family with ornithine carbamoyltransferase deficiency. Zhou Y; Jiang X; Zhang Y; Zhang Y; Sun F; Ma Y BMC Pregnancy Childbirth; 2024 Jul; 24(1):491. PubMed ID: 39039447 [TBL] [Abstract][Full Text] [Related]
3. Late-Onset Ornithine Transcarbamylase Deficiency and Variable Phenotypes in Vietnamese Females With Nguyen HH; Khanh Nguyen N; Dung Vu C; Thu Huong Nguyen T; Nguyen NL Front Pediatr; 2020; 8():321. PubMed ID: 32793520 [No Abstract] [Full Text] [Related]
4. Father-to-daughter transmission in late-onset OTC deficiency: an underestimated mechanism of inheritance of an X-linked disease. Siri B; Olivieri G; Lepri FR; Poms M; Goffredo BM; Commone A; Novelli A; Häberle J; Dionisi-Vici C Orphanet J Rare Dis; 2024 Jan; 19(1):3. PubMed ID: 38167094 [TBL] [Abstract][Full Text] [Related]
6. Neonatal Presentation of Ornithine Transcarbamylase Deficiency Associated With a Hypomorphic OTC Variant (p.Leu301Phe) Previously Reported in Later-Onset Disease. Anderson S; Ciarlariello M; Botti C; Velinov M Cureus; 2024 Aug; 16(8):e65956. PubMed ID: 39221296 [TBL] [Abstract][Full Text] [Related]
7. Hyperammonemia crisis following parturition in a female patient with ornithine transcarbamylase deficiency. Kido J; Kawasaki T; Mitsubuchi H; Kamohara H; Ohba T; Matsumoto S; Endo F; Nakamura K World J Hepatol; 2017 Feb; 9(6):343-348. PubMed ID: 28293384 [TBL] [Abstract][Full Text] [Related]
8. Estimation of the total number of disease-causing mutations in ornithine transcarbamylase (OTC) deficiency. Value of the OTC structure in predicting a mutation pathogenic potential. Arranz JA; Riudor E; Marco-Marín C; Rubio V J Inherit Metab Dis; 2007 Apr; 30(2):217-26. PubMed ID: 17334707 [TBL] [Abstract][Full Text] [Related]
9. A promoter variant in the OTC gene associated with late and variable age of onset hyperammonemia. Han ST; Anderson KJ; Bjornsson HT; Longo N; Valle D J Inherit Metab Dis; 2022 Jul; 45(4):710-718. PubMed ID: 35605046 [TBL] [Abstract][Full Text] [Related]
10. An integrated approach to the diagnosis and prospective management of partial ornithine transcarbamylase deficiency. Scaglia F; Zheng Q; O'Brien WE; Henry J; Rosenberger J; Reeds P; Lee B Pediatrics; 2002 Jan; 109(1):150-2. PubMed ID: 11773558 [TBL] [Abstract][Full Text] [Related]
11. Impact of enzyme activity assay on indication in liver transplantation for ornithine transcarbamylase deficiency. Wakiya T; Sanada Y; Urahashi T; Ihara Y; Yamada N; Okada N; Ushijima K; Otomo S; Sakamoto K; Murayama K; Takayanagi M; Hakamada K; Yasuda Y; Mizuta K Mol Genet Metab; 2012 Mar; 105(3):404-7. PubMed ID: 22264779 [TBL] [Abstract][Full Text] [Related]
12. Mutation Study of Malaysian Patients with Ornithine Transcarbamylase Deficiency: Clinical, Molecular, and Bioinformatics Analyses of Two Novel Missense Mutations of the Ali EZ; Zakaria Y; Mohd Radzi MA; Ngu LH; Jusoh SA Biomed Res Int; 2018; 2018():4320831. PubMed ID: 30175132 [TBL] [Abstract][Full Text] [Related]
13. The phenotypic and mutational spectrum of Thai female patients with ornithine transcarbamylase deficiency. Chongsrisawat V; Damrongphol P; Ittiwut C; Ittiwut R; Suphapeetiporn K; Shotelersuk V Gene; 2018 Dec; 679():377-381. PubMed ID: 30223008 [TBL] [Abstract][Full Text] [Related]
14. Disease-causing mutations in the promoter and enhancer of the ornithine transcarbamylase gene. Jang YJ; LaBella AL; Feeney TP; Braverman N; Tuchman M; Morizono H; Ah Mew N; Caldovic L Hum Mutat; 2018 Apr; 39(4):527-536. PubMed ID: 29282796 [TBL] [Abstract][Full Text] [Related]
15. Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency. Imoto K; Tanaka M; Goya T; Aoyagi T; Takahashi M; Kurokawa M; Tashiro S; Kato M; Kohjima M; Ogawa Y BMC Gastroenterol; 2022 Mar; 22(1):144. PubMed ID: 35346058 [TBL] [Abstract][Full Text] [Related]
16. Are asymptomatic carriers of OTC deficiency always asymptomatic? A multicentric retrospective study of risk using the UCDC longitudinal study database. Sen K; Izem R; Long Y; Jiang J; Konczal LL; McCarter RJ; ; Gropman AL; Bedoyan JK Mol Genet Genomic Med; 2024 Apr; 12(4):e2443. PubMed ID: 38634223 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic and Management Issues in Patients with Late-Onset Ornithine Transcarbamylase Deficiency. Ibrahim MS; Gold JI; Woodall A; Yilmaz BS; Gissen P; Stepien KM Children (Basel); 2023 Aug; 10(8):. PubMed ID: 37628367 [TBL] [Abstract][Full Text] [Related]
18. Hyperammonemia in ornithine transcarbamylase-deficient recipients following living donor liver transplantation from heterozygous carrier donors. Rahayatri TH; Uchida H; Sasaki K; Shigeta T; Hirata Y; Kanazawa H; Mali V; Fukuda A; Sakamoto S; Kasahara M Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27891735 [TBL] [Abstract][Full Text] [Related]
19. [Consensus on diagnosis and treatment of ornithine trans-carbamylase deficiency]. Division of Genetics and Metabolism, Child Diseases and Health Care Branch, Chinese Association for Maternal and Child Health Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 49(5):539-547. PubMed ID: 33210478 [TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and molecular genetic analysis of ten cases of ornithine carbamoyltransferase deficiency in southeastern China. Yuan G; Liu Z; Chen Z; Zhang X; Zhang W; Chen D Ital J Pediatr; 2024 Sep; 50(1):171. PubMed ID: 39256843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]